Dr Reddy's inks pact with Coya Therapeutics for investigational ALS therapy COYA 302

Dr Reddy's Laboratories SA, a subsidiary of Dr Reddy's Laboratories, has signed a development and licence agreement with Coya Therapeutics Inc for the development and commercialisation of COYA 302, a combination biologic therapy for ALS. Dr Reddy's will have an exclusive licence to commercialise COYA 302 in the US, Canada, EU,...